Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy

The complement system plays a key role in myasthenia gravis (MG). Anti-complement drugs are emerging as effective therapies to treat anti-acetylcholine receptor (AChR) antibody-positive MG patients, though their usage is still limited by the high costs. Here, we searched for plasma complement protei...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Nicola Iacomino, Fiammetta Vanoli, Rita Frangiamore, Marta Ballardini, Letizia Scandiffio, Federica Bortone, Francesca Andreetta, Fulvio Baggi, Pia Bernasconi, Carlo Antozzi, Paola Cavalcante, Renato Mantegazza
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Subjects:	myasthenia gravis autoimmunity biomarkers complement system anti-complement therapy
Online Access:	https://www.mdpi.com/2227-9059/10/6/1360